| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Dec 01, 2025 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,286.00
Est. +22%
|
$1,057.89 | $1,182.73 |
Pending
|
$1,133.00
+7.1%
|
| Oct 01, 2025 |
Pfizer Inc.
PFE
|
BUY |
$28.00
Est. +3%
|
$27.16 | $28.75 |
Precision Hit (±3%)
|
$26.21
-3.5%
|
| Apr 12, 2023 |
Cardinal Health, Inc.
CAH
|
BUY |
$127.00
Est. +60%
|
$79.19 | - | - |
$223.85
+182.7%
|
| Feb 04, 2022 |
Biogen Inc
BIIB
|
SELL |
$217.00
Est. +2%
|
$221.53 | - | - |
$200.05
+9.7%
|
| Nov 03, 2021 |
Pfizer Inc.
PFE
|
BUY |
$46.00
Est. +4%
|
$44.09 | - | - |
$26.21
-40.6%
|
| Nov 03, 2021 |
AMGEN Inc.
AMGN
|
BUY |
$230.00
Est. +7%
|
$214.47 | - | - |
$355.20
+65.6%
|
| Oct 29, 2021 |
Merck & Co Inc
MRK
|
BUY |
$94.00
Est. +9%
|
$86.45 | - | - |
$119.05
+37.7%
|
| May 03, 2021 |
Abbvie Inc
ABBV
|
BUY |
$127.00
Est. +15%
|
$110.91 | - | - |
$227.73
+105.3%
|